AR055286A1 - ACID BENCENOSULFONATE (1ALFA, 3ALFA, 5ALFA) - (3- (AMINOMETIL) BICYCLE (3.2.0) HEPT-3-IL) ACETIC - Google Patents

ACID BENCENOSULFONATE (1ALFA, 3ALFA, 5ALFA) - (3- (AMINOMETIL) BICYCLE (3.2.0) HEPT-3-IL) ACETIC

Info

Publication number
AR055286A1
AR055286A1 ARP050104900A AR055286A1 AR 055286 A1 AR055286 A1 AR 055286A1 AR P050104900 A ARP050104900 A AR P050104900A AR 055286 A1 AR055286 A1 AR 055286A1
Authority
AR
Argentina
Prior art keywords
hept
acid
acetic
bencenosulfonate
3alfa
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR055286A1 publication Critical patent/AR055286A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente proporciona la sal bencenosulfonato del ácido (1alfa, 3alfa, 5alfa)-[3-(aminometil)biciclo[3.2.0]hept-3-il]acético que tiene la formula estructural (1), este compuesto es particularmente adecuado como una sustancia fármaco y es util en el tratamiento de dolor, epilepsia y otras afecciones. Reivindicacion 1: La sal bencenosulfonato del ácido (1alfa, 3alfa, 5alfa)-[3-(aminometil)biciclo[3.2.0]hept-3-il]acético que tiene la formula estructural (1).The present provides the benzenesulfonate salt of (1alpha, 3alpha, 5alpha) - [3- (aminomethyl) bicyclo [3.2.0] hept-3-yl] acetic acid having the structural formula (1), this compound is particularly suitable as a drug substance and is useful in the treatment of pain, epilepsy and other conditions. Claim 1: The benzenesulfonate salt of the acid (1alpha, 3alpha, 5alpha) - [3- (aminomethyl) bicyclo [3.2.0] hept-3-yl] acetic acid having the structural formula (1).

ARP050104900 2004-11-25 2005-11-23 ACID BENCENOSULFONATE (1ALFA, 3ALFA, 5ALFA) - (3- (AMINOMETIL) BICYCLE (3.2.0) HEPT-3-IL) ACETIC AR055286A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425955A GB0425955D0 (en) 2004-11-25 2004-11-25 Salt form

Publications (1)

Publication Number Publication Date
AR055286A1 true AR055286A1 (en) 2007-08-15

Family

ID=33561369

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104900 AR055286A1 (en) 2004-11-25 2005-11-23 ACID BENCENOSULFONATE (1ALFA, 3ALFA, 5ALFA) - (3- (AMINOMETIL) BICYCLE (3.2.0) HEPT-3-IL) ACETIC

Country Status (3)

Country Link
AR (1) AR055286A1 (en)
GB (1) GB0425955D0 (en)
TW (1) TW200626528A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102142257B1 (en) * 2013-04-04 2020-08-07 다이이찌 산쿄 가부시키가이샤 Solid composition of amino carboxylate salt

Also Published As

Publication number Publication date
GB0425955D0 (en) 2004-12-29
TW200626528A (en) 2006-08-01

Similar Documents

Publication Publication Date Title
NO20062704L (en) Azabicyclic heterocycles as cannabinoid receptor modulators
ATE525351T1 (en) SUBSTITUTED N-PHENYL-BIPYRROLIDINECARBONIC ACID AMIDES AND THEIR THERAPEUTIC USE
PE20021031A1 (en) CONDENSED BICYCLE OR TRICYCLE AMINO ACIDS
DK2121691T3 (en) Spirocyclic cyclohexane derivatives
NO20065904L (en) Therapeutic compounds
DK1192212T3 (en) Use of cyclohexane polycarboxylic acids as plasticizers for the production of plastics to be classified as toxicologically beneficial
ATE525350T1 (en) SUBSTITUTED N-PHENYL-BIPYRROLIDINECARBONIC ACID AMIDES AND THEIR THERAPEUTIC USE
ATE502633T1 (en) CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF EYE DISEASES
MX2009012163A (en) Hetarylanilines as modulators for amyloid beta.
WO2007062078A3 (en) Thrombopoietin activity modulating compounds and methods
AR026087A1 (en) BICYCLE AMINO ACIDS AS PHARMACEUTICAL AGENTS.
EA200800303A1 (en) APPLICATION OF DERIVATIVES AND ANALOGUES OF THIAZOLE IN VIOLATIONS CAUSED BY FREE FATTY ACIDS
PE20050011A1 (en) DIPHENYLAZETIDINONE COMPOUND WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCEDURE FOR ITS PREPARATION AND DRUGS INCLUDING THIS COMPOUND
NI200900074A (en) TREATMENT OF GENERALIZED DEVELOPMENTAL DISORDERS
NO20076357L (en) Azabicyclic heterocycles as cannabinoid receptor modulators
BRPI0919020A2 (en) USE OF ENRICHED MONOCYTE LINE CELLS TO TREAT ISCHEMIA AND TO TREAT ANGINA PECTORIS
PE20051156A1 (en) ORAL MATRIX FORMULATIONS INCLUDING LICARBAZEPINE
EA200601845A1 (en) NEW β-AGONISTS, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS MEDICINE
ECSP099308A (en) METHODS OF TREATMENT OF DEPRESSION
DE502004008819D1 (en) MEDICAMENT FOR GROWTH INHIBITION OF TUMORS
ATE437855T1 (en) (4,5,6,7-TETRAHYDRO-1H-INDOL-7-YL)ACETIC ACID DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
AR055286A1 (en) ACID BENCENOSULFONATE (1ALFA, 3ALFA, 5ALFA) - (3- (AMINOMETIL) BICYCLE (3.2.0) HEPT-3-IL) ACETIC
RU2008101661A (en) SUBSTITUTED CYCLIC CONNECTION, METHOD OF ITS PRODUCTION AND ITS MEDICINAL USE
BRPI0513222A (en) agent for promoting recovery from dysfunction after the onset of central neurological disease
BR0010225A (en) Amide compound, process for preparing it, pharmaceutical composition comprising said compound, method of treatment and use

Legal Events

Date Code Title Description
FB Suspension of granting procedure